Substituted imidazoles having anti-cancer and cytokine inhibitory activity
US6548520B1 · kind B1 · utility
10Cited by
23References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2001 |
| Grant date | Apr 15, 2003 |
| Priority date | — |
| Expiry date | Mar 3, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is related to novel 2-alkyl substituted imidazoles of formula (I) useful for the treatment of CSBP kinase mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.